108 related articles for article (PubMed ID: 7508027)
1. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Konishi F; Inagami T
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
[TBL] [Abstract][Full Text] [Related]
2. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Naruse M; Sakakibara M; Inagami T
Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
5. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
[TBL] [Abstract][Full Text] [Related]
6. A Na pump inhibitor from bovine posterior pituitary: purification, structure determination and its cardiovascular effect in rat.
Hamakubo T; Furuta H; Ichimura M; Appalsamy M; Mosqueda-Garcia R; Robertson D; Inagami T
Biochem Biophys Res Commun; 1992 Dec; 189(2):691-6. PubMed ID: 1335244
[TBL] [Abstract][Full Text] [Related]
7. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
9. Purification and properties of endogenous ouabain-like substances from hemofiltrate and adrenal glands.
Schoner W; Heidrich-Lorsbach E; Kirch U; Ahlemeyer B; Sich B
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S29-31. PubMed ID: 7508021
[TBL] [Abstract][Full Text] [Related]
10. Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine.
Levine BH; Murray ED; Bigornia AE; DeWind SA; Wechter WJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S63-8. PubMed ID: 7508032
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
[TBL] [Abstract][Full Text] [Related]
12. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
13. Specific endogenous Na, K-ATPase inhibitor purified from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochem Biophys Res Commun; 1987 Dec; 149(2):468-74. PubMed ID: 2827643
[TBL] [Abstract][Full Text] [Related]
14. A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
Gentile DA; Skoner DP
Clin Exp Allergy; 1996 Dec; 26(12):1449-60. PubMed ID: 9027446
[TBL] [Abstract][Full Text] [Related]
15. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of a ouabain-like factor from Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S75-8. PubMed ID: 7508036
[TBL] [Abstract][Full Text] [Related]
17. Plasma endogenous sodium pump inhibitor in essential hypertension.
Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
[TBL] [Abstract][Full Text] [Related]
18. An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia.
Sohn HJ; Stokes GS; Johnston H
J Lab Clin Med; 1992 Aug; 120(2):264-71. PubMed ID: 1323635
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
Inagami T; Tamura M
Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
[TBL] [Abstract][Full Text] [Related]
20. Recent progress on an endogenous digitalislike factor in hypertension.
Cloix JF; Crabos M; Meyer P
J Clin Hypertens; 1986 Jun; 2(2):93-100. PubMed ID: 3020179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
